Market Research Blog

[318 Pages Report] According to a recent research study published by Future Market Insights, the global dialysis equipment market is projected to register a CAGR of 4.8% and will likely reach a valuation of US$ 23.6 Bn by 2028 end. The medical sector meanwhile continues to introduce newer dialysis equipment in the global market to address the varied needs of patients.

Patients with end-stage renal disease (ESRD) currently have two treatment options – kidney transplant and dialysis. The limited number of kidney donors worldwide and the various medical complications that arise from dialysis have pushed the medical fraternity to look for suitable alternatives to treat ESRD. Implantable bio artificial kidneys are the latest innovation in healthcare science that provide the health benefits of kidney transplantation and potentially wipe out the need for dialysis. Powered by silicon nanotechnology, artificial kidneys seek to eliminate the torture faced by dialysis patients and may prove to be a boon to patients with acute renal failure.

Get a Sample Copy of the Report@ https://www.futuremarketinsights.com/reports/sample/REP-GB-711

In a new development, the Kidney Research Institute of the University of Washington is currently developing a wearable artificial kidney that is expected to go into clinical trials in 2022. This could be a game changer in the medical devices sector, and may reduce the dependency on dialysis equipment to a great extent.

Dialysis Continues to Remain Dominant Therapy to Treat ESRD

While developments in the global healthcare sector continue to focus on innovative products and therapies, dialysis is currently the most administered treatment option for ESRD. Dialysis equipment is in great demand in hospitals, clinics, and dialysis centres across the world, boosting demand in the global market. According to a recent research study published by Future Market Insights, the global dialysis equipment market is projected to register a CAGR of 4.8% and will likely reach a valuation of US$ 23.6 Bn by 2028 end. The medical sector meanwhile continues to introduce newer dialysis equipment in the global market to address the varied needs of patients.

Portable Home Dialysis Equipment Trending the Global Market

Home dialysis has remained a preferred option for patients with renal disease as it is more convenient and less expensive than hospital based dialysis. Leading medical devices manufacturer Quanta has recently launched advanced haemodialysis equipment with an objective to improve the lives of patients requiring dialysis on a regular basis. This is an extremely flexible dialysis treatment that patients can take in the comfort of their homes. Quanta’s home dialysis equipment is portable, lightweight, and very easy to use. This dialysis equipment also incorporates advanced technology such as high-res screens with touchscreen functionalities and helps enhance patient outcomes.

Manufacturers of dialysis equipment are developing fully automatic, portable, and advanced dialysis equipment to treat patients of all ages suffering from ESRD. A notable technological advancement includes the introduction of high-efficiency and high-flux membranes, enabled by technical advances in membrane technology and polymer chemistry. Unlike traditional renal replacement machines, automated dialysis equipment facilitates the management of disease parameters digitally, thereby ensuring more accuracy and reducing costs of labour.

For critical insights, request for PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-711

Wearable Dialysis Equipment to Ease Patient Discomfort; Expected to Rule the Global Market

With technology having proliferated every aspect of human lives, the innovation of wearable dialysis equipment is a blessing for countless dialysis patients, who can now break the shackles of confinement to fixed dialysis equipment and enjoy increased mobility. Wearable dialysis equipment is a miniature artificial HD machine based on dialysate regenerating sorbent technology. Designed for use as a belt, patients can wear this dialysis equipment for slow, gentle dialysis. This dialysis equipment is touted to best mimic the natural kidney function of blood cleansing. Given the continuous advancements taking place in medical device technology, wearable dialysis equipment may soon emerge in a more compact and small form factor to provide increased convenience and usability to patients.

Why Future Market Insights?

• Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The performance of the global muscle stimulation devices market is expected to witness immensely impactful developments, with potential improvements in the recovery of stroke through nerve stimulation. With rising rate of AIS (acute ischemic stroke), the focus has been shifted to improving the associated stages of stroke care, including prevention, intervention, and rehabilitation. The Ohio State University has been conducting a new clinical trial to shorten the motor skills recovery period in stroke patients, via VNS (vagus nerve stimulation).

Request For Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1140

The trial involves the use of a device – Vivistim, which has been developed by MicroTransponder, a Dallas-based company. The device functions by coupling VNS with the muscle movement, during rehabilitation. It is supposed to build up the motor function, learning, and memory, drastically improving the post-stroke outcome thereby. This nerve stimulation therapy, if used in tandem with appropriate interventions, can potentially result in excellent rehabilitation, minimizing the impact of complications that may follow the treatment process. If Vivistim delivers positive results and enables stroke patients to regain their motor function early, the market participants may witness multiple doors of opportunities in the rehabilitative treatment area.

Key Companies to Focus on Strong Distribution Channel Development & Suppliers to Strengthen Presence in Emerging Markets

New and innovative product launches such as wireless devices are being considered by manufacturers as the key to achieve enhanced device capabilities, which is presumed to trigger sales in long term. To expand market shares and improve distribution network through the next decade, several players are prioritizing strategic partnerships, i.e. distribution agreements for their product offerings. Enhanced distribution will also help the stakeholders penetrate various untapped regional markets.

Any Questions, Reach Out To Us @  https://www.futuremarketinsights.com/ask-question/rep-gb-1140

Key players in the global muscle stimulation devices market are focusing on development of new pain management methods and techniques. Adoption of innovative marketing strategy by muscle stimulation device manufacturers is attributed to their gradually increasing market value share. Increased focus on strengthening of distribution channel will reportedly be the key for market expansion in emerging economies. On the flipside, suppliers are likely to consider patient needs as a top priority, while ensuring the supply of high-quality products to end users. Stakeholders are strengthening product portfolio by launching new products with improved features, and through strategic mergers and acquisitions. Moreover, a growing number of local players in the muscle stimulation devices market is expected to result in creating a fragmented market, since the market is already led by smaller-sized firms catering to domestic customer demands.

Muscle Stimulation Devices to Face Passive Growth

Despite immense scope for innovation in product development and applications, the global market for muscle stimulation devices is projected to observe sluggish growth over the next decade. As prompted by a recent research study by Future Market Insights, the global muscle stimulation devices market will expand at a CAGR of 3.9% during 2018-2028, attaining a value of over US$ 870 Mn by 2028 end. High price point will remain a longstanding factor limiting widespread adoption of muscle stimulators. Stringent regulatory norms regarding the launch and use of muscle stimulation devices is also anticipated to hinder market growth in upcoming decade.

By value, North America and Western Europe are expected to represent the dominant markets for muscle stimulation devices, whereas developing economies such as APEJ, Latin America, and Eastern Europe will reportedly exhibit relatively promising performance over the projection period.

Buy Industry Research Report @ https://www.futuremarketinsights.com/checkout/1140

Key Segments

The next section analyses market on the basis of product type and presents forecast in terms of value (US$ Mn) for the next 10 years. Product types included in the report are-

• Neuromuscular Electric Stimulator (NMES)
• Transcutaneous Electric Nerve Stimulator (TENS)
• Interferential (If)
• Burst Mode Alternating Current

The next section analyses market on the basis of indication and presents forecast in terms of value (US$ Mn) for the next 10 years The global muscle stimulation devices market is segmented on the basis of application into:

• Pain Management
• Neurological & Movement Disorder Management
• Musculoskeletal Disorder Management

The next section analyses the market on the basis of the end user and presents forecast in terms of value (US$ Mn) for the next 10 years. On the basis of the end user, the global muscle stimulation devices market is categorized into:

• Hospitals
• Physiotherapy Clinics
• Sports Clinics
• Home Care Settings

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[194 Pages Report] The global Orthokeratology Market is expected to be worth US$ 58.1 million in 2022, rising to US$ 88.7 million by 2028, at a CAGR of 7.3 percent from 2022 to 2028.

Orthokeratology has been considered to facilitate the elimination of contact lens related vision problems, providing patients with the freedom to experience an active lifestyle.

While this factor will continue to play a pivotal role in growing adoption of Ortho-K lenses, Future Market Insights has discovered a few other factors that are likely to impact the growth of orthokeratology market in near future. In a recently released report, titled “Orthokeratology Market: Global Industry Analysis 2013-2021 and Opportunity Assessment, 2022–2028,” the performance of global market for orthokeratology is assessed for a 10-year period 2022-2028.

Increasing online efforts in patient education and awareness about Ortho-K, coupled with an intensifying rate of success of orthokeratology lenses in recent years, is expected to strengthen the prospects for global orthokeratology market, over the next decade. The market is likely to witness a promising CAGR of 7.4%; whereas, the global revenue is anticipated to reach beyond US$ 88 million by the end of 2028.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3142

While increasing prevalence of myopia stands as a key factor impacting the market growth, several advantages of Ortho-K lenses over the conventional contact lenses have been recognized to be pushing adoption of orthokeratology among sports persons. A few restrictions arising in case of LASIK surgery will also be reportedly responsible for growing inclination for Ortho-K. On the flipside, the adoption of orthokeratology lenses among the myopic patient is less than 0.5%, which is a major factor deterring the growth of the market. In few under developing economies, patient are not able afford the high cost of ortho-k lenses and also the high fees of ophthalmologists and optometrists which will also deter the growth of market to some extent.

Myopia Continues to Remain the Most Influencing Indication, Accounting for a Major Revenue Share

Myopia is expected to remain a key indication driving the demand for orthokeratology, worldwide. With over 70% share of the total market value estimated for 2028, myopia will also provide an extensive scope for innovation opportunities. Hyperopia, followed by astigmatism, will represent the next key indicative factor, which is anticipated to drive market growth over the forecast period.

Get a Customized Scope to Match Your Need, Ask an Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3142

Demand from Optometry Clinics Accounts for a Share that Equates More than Half of the Market Value

Among all distribution channels, optometry clinics will reportedly continue to generate the maximum demand for Ortho-K, accounting for a share of more than 50% to the total market value through 2028. Ophthalmic clinics are expected to hold a decent revenue share throughout the assessment period, whereas hospitals are likely to emerge as the most opportunistic distribution channel.

MEA Still Struggles through Low Awareness Level

North America and Europe, which represent the key regional markets, will reportedly account for a collective value share of around 60% through 2028. Asia Pacific excluding China and Japan is slated for modest growth, whereas MEA will continue to witness sluggish growth rate owing to relatively lower consumer awareness about availability and use of Ortho-K lenses.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/3142

Key Players :

• The Cooper Companies Inc.
• Euclid Systems Corporation
• Menicon Co., Ltd.
• GP Specialists, Inc.
• TruForm Optics, Inc.
• Art Optical Contact Lens, Inc.
• MiracLens L.L.C.
• Contex, Inc.

Key Segments Covered in Orthokeratology Industry Survey

Orthokeratology Market by Indication:

• Myopia
• Presbyopia
• Hyperopia
• Astigmatism

Orthokeratology Market by Distribution Channel:

• Hospitals
• Optometry Clinics
• Ophthalmology Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

The global veterinary lasers market is predicted to take a leap from US$ 123.2 Mn (2017) to a value worth US$ 336.5 Mn by the end of 2028. According to the latest market research report published on the global market for veterinary lasers by Future Market Insights, the global veterinary lasers market is projected to register a robust CAGR of 9.7% in terms of value during the forecast period 2018–2028. The report, titled “Veterinary Lasers Market – Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028” provides detailed analysis of the market over the next decade.

Pet Ownership Prevails and Availability of Pet Healthcare Widens

Significant rise in the percentage of pet owners and increasing spending on pets by owners have been the key factors driving the demand for veterinary lasers over the years. Furthermore, a rising number of government and private collaborations to provide quality care to pets will also provide an impetus to the global market for veterinary lasers in near future. Upgradation of veterinary hospitals and clinics that has been creating significant impact on the overall market scenario, coupled with an increasing number of healthcare facilities, will reportedly push the veterinary lasers market a little farther.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-5410

Pet Owners Continue to Look for Non-invasive Treatment Options Through Insurance Cover

Improving implementation of pet insurance coverage is identified to act as a value-driver to market growth during the assessment period. The demand for non-invasive procedures is increasing among pet owners and a majority of them have already accepted laser therapies as a better, efficient, and less painful treatment alternative for pets. This factor will continue to play a crucial role in strengthening the market conditions in upcoming years.

High Costs and Lack of Favorable Reimbursement Policies to Remain Longstanding Challenges

Although probable health risks and expensive costs associated with laser therapies may hamper the penetration of lasers worldwide, Future Market Insights estimates promising growth prospects for the market over 2018-2028. A few other restraints to the growth of market include inadequacy of reimbursement policies in emerging economies, dearth of trained and skilled specialists and professionals, and absence of top notch healthcare infrastructure in certain regions of the world.

Veterinary Lasers Market Segments, Market Dynamics, Market Size, Supply & Demand, Current Trends/Issues/Challenges, Competition & Companies involved, Technology, Pricing, Value Chain: https://www.futuremarketinsights.com/reports/veterinary-lasers-market

Therapeutic and Class 3 Lasers Dominate, Hospitals Continue to Record Maximum Consumption

By product type, therapeutic lasers segment accounted for more than 44% share of the total market revenue in 2017. Future Market Insights estimates continued dominance of this segment and rapid emergence of therapeutic and surgical lasers segment during the forecast period. Based on laser type, class 3 lasers segment is expected to win over class 2 and class 4 lasers segments, accounting for more than 46% share of the market value by 2028 end. Hospitals will reportedly remain the largest end-user of veterinary lasers, capturing over 40% market value share throughout the assessment period.

The Americas Remain the Leading Region, Developing Economies Witness Healthy Growth

The North American market for veterinary lasers is anticipated to continue dominance over all other regional markets throughout the forecast period. With an estimated CAGR of 10.8% in terms of value, North America will possibly reach a value beyond US$ 99 Mn by the end of 2028. Latin America, although a developing country, will register a significant CAGR over the forecast period and remain the second largest as well as second fastest growing regional market for veterinary lasers. The Americas will be followed by the European market, in terms of both value and growth rate. According to the report, emerging economies are presumed to experience robust growth over the projection period.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep-gb-5410

Some of the Key Players Competing in the Global Veterinary Lasers Market, Profiled in the Report:

• Cutting Edge Laser Technologies
• Aesculight Llc
• LiteCure LLC
• Respond Systems, Inc.
• Pivotal Health Solutions
• Laserex Technologies Pty Ltd
• ERCHONIA CORPORATION,
• Technological Medical Advancements, Inc.
• BIOLASE, Inc.

More from FMI’s Healthcare, Pharmaceuticals and Medical devices Market Intelligence:

• Veterinary Ultrasound Scanners Market Veterinary Ultrasound Scanners Market Segmentation By Product Type – Portable/Hand Held, Cart Based Ultrasound Scanner; By Market Size – Veterinary Hospitals, Veterinary Clinics, Animal Breeding and Farms; By Technology – Digital Imaging, Analog Imaging, Others

• Veterinary Vaccines Market Veterinary Vaccines Market Segmentation By Product – Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines and Recombinant Vaccines; By Disease Application Type – Anaplasmosis, Canine Parvovirus, Foot and Mouth Disease, Newcastle Disease, Distemper Disease, Influenza, PRRS and Others; By Animal Type – Companion Animals, Livestock Animals and Equine; By Distribution Channel – Veterinary Clinics, Veterinary Hospitals, and Others

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

According to a recent report by Future Market Insights (FMI), rising prevalence of pelvic organ prolapse (POP) and stress urinary incontinence (SUI) is expected to boost the growth opportunities for female pelvic implants market. The market is set to reach a valuation of US$ 245 Mn in 2021, rising at a CAGR of 2.8% through the end of 2031.

According to the American Urological Association (AUA/SUFU), the incidence of stress urinary incontinence (SUI) in women was reported to be as high as 49%. The incidence of stress urinary incontinence is high in women with poor or weakened pelvic supports. This disease affects the lives of women to a great extent and is widespread in the older population.

Increasing incidence of vaginal disorders among aged women coupled with the non-availability of other treatment options for SUI and POP will continue increasing the demand in the female pelvic implants market. According to the U.S. FDA, the number of women who have POP is estimated to surge by 46%, to 4.9 million, by 2050.

Get Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-3422

However, the low rate of efficacy after pelvic implantation and the problems of pelvic organ prolapse are hampering the growth of the female pelvic implants market.  COVID-19 is anticipated to have a moderately negative impact on the female pelvic implants market due to implementation of lockdown. Supplies and demand were jolted by the massive spread of the infection, which staggered the growth of the female pelvic implants market.

Key Takeaways from Female Pelvic Implants Market Study

• Vaginal sling/tapes demand is anticipated to gain maximum revenue share of more than 68%, rising at an expected CAGR of 2.5% owing to the high demand to treat stress urinary incontinence.
• Hospitals followed by ambulatory surgical centers are leading users of female pelvic implants growing owing to the rising number of POP and SUI patients.
• The U.S. accounts for more than 83% of the North America market, driven by the high incidence of pelvic organ prolapse.
• The U.K.is a leading market in Europe. It is expected to account for nearly 13% of demand registered in Europe by 2031. Implementation of government funded awareness programs will remain a chief growth driver.
• Over 30% of the South Asia market is held by India. Growth in the country is propelled by significant investments in the expansion of healthcare sector.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3422

Post-Marketing Surveillance of Approved Devices Influencing Female Pelvic Implants Demand

An increasing number of manufacturers are continuing to sell their products in the global market despite restrictions by law. After the FDA reclassification of vaginal mesh implants from Class II to Class III medical devices, the FDA has advised 33 manufacturers to conduct 3-year studies to assess impacts of organ damage and other complications of mesh implants.

After assessing the risks, manufacturers can reintroduce their devices and can get pre-market approval from the FDA. This allows manufacturers to re-launch the mesh implants, which is expected to come into the market by 2022.

Who is Winning?

Key players in the market are focusing on strategic collaborations, acquisitions, and expansion. Furthermore, product launches, agreements and research sponsorships are key strategies adopted by manufacturers to strengthen their product portfolios in the female pelvic implants market.

For instance, Coloplast acquired Nine Continents Medical, Inc. in November 2020 and aimed to expand its medical device product portfolio.

The FDA, in 2019 completed its broad evaluation of data associated with the resin used in the production of Boston Scientific’s vaginal mesh through which, the US federal law limits these devices to sale by order of a surgeon.

Want More Insights?

Future Market Insights (FMI) brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global Female Pelvic Implants Market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on the Female Pelvic Implants Market on basis of product type [Vaginal Mesh Implants, Vaginal Sling/Tape and Vaginal Graft Implants], Indication [Pelvic Organ Prolapse (POP) and Stress Urinary Incontinence (SUI)]. Based on End User [Hospitals, Ambulatory Surgical Centers and Specialized Clinics] across seven major regions.

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-3422

Market Taxonomy Product Type

• Vaginal Mesh Implants
• Vaginal Sling
• Vaginal Graft Implants

Indication

• Pelvic Organ Prolapse
• Stress Urinary Incontinence

End User

• Hospitals
• Ambulatory Surgical Centres
• Speciality Clinics

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[275 Pages Report] Global demand for actinic keratosis treatment, majorly driven by that in the U.S. and European countries, continues to grow at a strong rate. Poised for revenues of over US$ 4 Bn by the end of 2019, the global actinic keratosis treatment market will exhibit an impressive CAGR of 7% during the forecast period (2019 – 2029).

The understanding about the nature of actinic keratosis and the potential risk of this condition progressing to squamous cell carcinoma (SCC) is improving, among patients as well as healthcare providers. Especially among the elderly, actinic keratosis remains one of the most commonly diagnosed dermatological condition that creates a continued need for efficacious treatments.

Who Is Winning?

The actinic keratosis treatment market report tracks the key market players, which includes GlaxoSmithKline Plc. Nestle SA, Novartis AG, Sun Pharmaceutical Ltd., Leo Pharma Inc. etc. Leading manufacturers in the actinic keratosis treatment market are focusing on acquisitions to enhance their product portfolio. For instance, in November 2015, Leo Pharma A/S completed the acquisition of dermatology business of Astellas Pharma. With this acquisition, the company expanded its dermatology product portfolio segment. Companies are also focusing on segment leadership. In February 2016, Cipher Pharmaceuticals Inc. launched Actikerall for the topical treatment of slightly palpable and/or moderately thick hyperkeratotic actinic keratosis to mark their leadership in topical product segment.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-3233

Combination therapies such as topical fluorouracil cryotherapy, PDT and imiquimod therapy, chemical peels, and 5-FU are generally the most prescribed therapies for actinic keratosis. Convenient administration, lower potential for irritation, and systemic absorption continue to underpin their high adoption rate. Development of drugs with increased efficacy and decreased side effects that can be used as combination therapy for actinic keratosis treatment is currently the focal point of global market leaders. Biofrontera AG commercially launched its product Ameluz (2016), used in combination with PDT for actinic keratosis treatment.

Development of minimally invasive drug-device combination therapies and fast track regulatory approval for pipeline drugs will be offering a completely new set of treatment options for actinic keratosis in the near future.

Key Takeaways – Actinic Keratosis Treatment Market Study

• Growing use of topical products as the first-line preference for actinic keratosis treatment is offering huge opportunities to market players to develop and launch new topical products for actinic keratosis treatment.
• Increasing collaboration activities by key market players of the actinic keratosis treatment market with other companies to broaden their products portfolio is anticipated to propel the actinic keratosis treatment market growth.
  • For instance, in March 2017, Galderma SA (Nestle Skin Health Company) collaborated with Colorescience, to enhance its product portfolio for aesthetic treatment.
• Increasing product approvals of actinic keratosis treatment by regulatory bodies is expected to fuel the actinic keratosis treatment market growth.
  • For instance, in March 2018, combination of Ameluz and daylight photodynamic therapy (PDT) by Biofrontera AG got approval from the European Union.
• The U.S. and Australia marking rise in incidence and prevalence of actinic keratosis will remain highly prominent markets for actinic keratosis treatment providers.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on actinic keratosis treatment market in its latest study, presenting historical demand assessment from 2014 – 2018 and projections from 2019 – 2029 on the basis of treatment category (topical treatment, procedural modality, photodynamic therapy and others), disease type (clinical AK and subclinical AK)and end-user (hospitals, laser therapy centers, private dermatology clinics, spas and rejuvenation centers, cancer treatment centers, homecare) in seven key regions.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-3233

Actinic Keratosis Treatment Market By Category

By Treatment Type:

• Topical Treatment
  • 5-fluorouracil Cream
  • Diclofenac Gel
  • Imiquimod Cream
  • Ingenol mebutate Gel
• Procedural Modality
  • Chemical Peels
  • Cryotherapy
• Photodynamic Therapy
• Others

By Disease Type:

• Clinical AK
• Subclinical AK

By End User:

• Hospitals
• Private Dermatology Clinics
• Laser Therapy Centers
• Cancer Treatment Centers
• Spas and Rejuvenation Centers
• Homecare

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

[215 Pages Report] [215 Pages Report] The global Aortic Stents Grafts Market is forecast to total US$ 2.15 Bn in 2022. With increasing preference for minimally invasive procedures, the overall market is projected to grow at 4.5% CAGR, reaching a valuation of around 2.8 Bn by 2028.

Future Market Insights delivers key insights and presents a revised forecast of the global aortic stent grafts market for a 10-year period from 2018 to 2028 in the report titled “Aortic Stent Grafts Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028.” The revision in the market size and volume forecasts has been carried out taking into account the impact of various macroeconomic indicators and other industry-based demand-driving factors, as well as the recent developments of the key market participants. In terms of revenue, the global aortic stent grafts market is projected to expand at a 7.6% CAGR over the forecast period of 2018–2028.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

[341 Pages] According to the latest market report published by Future Market Insights, titled ‘Global Amniotic Membrane Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028’, the global amniotic membrane market is expected to expand at a CAGR of 9.3% over the forecast period 2018–2028.

FMI estimates that the global market for amniotic membrane is to be valued at US$ 955.2 Mn in 2018 and is expected to expand at CAGR of 9.3% over 2018–2028, to surpass US$ 2,322 Mn by 2028 end. Based on product type, the cryopreserved amniotic membrane segment dominated the global amniotic membrane market, with over 70% value share in 2017. The segment is expected to grow at above 9% CAGR over the forecast period of 2018–2028. North America is expected to maintain its dominance in the global market due to regulatory approvals of several new products in the U.S.

Population of all age groups has emerged as a prominent consumer base, characterised by untapped product segments for amniotic membranes to offer effective wound healing and eye surgeries. This has prompted the amniotic membrane product manufacturers to capitalize on the emerging latent opportunity. The companies in the market are optimistic with regard to increasing amniotic membrane transplants and increasing demand for amniotic membrane products around the world, particularly in North American countries. It is more than likely that over the span of the next four to five years, the companies focus on developing innovative products and designing market level strategies to leverage the potential opportunities emerging in parallel with growing human population with various chronic diseases.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-5044

Amniotic membrane products such as Amniotic Allograft Membrane and Amniotic Allograft Suspension used to treat surgical wounds and defects of the corneal epithelia have gained traction over the last two decades. The major types of amniotic membranes such as cryopreserved amniotic membrane and lyophilized amniotic membrane have evolved back in the 1990s, but they became significant and the market for amniotic membranes to be used on humans boomed over the past fifteen years.

The global amniotic membrane market has been segmented on the basis of product type, application, end user and regions. Globally, cryopreserved amniotic membrane is the most attractive segment from manufacturers’ point of view. Cryopreserved amniotic membrane is majorly used in ocular surface eye surgery owing to its positive effect on wound healing due to its anti-inflammatory property. Among all end users of amniotic membrane, high demand for amniotic membrane is expected to come from the hospitals segment due to rising application of amniotic membrane in advanced surgical healing.

By volume, the global amniotic membrane market is expected to expand at 11.4% over the forecast period of 2018–2028. With nearly 43% market value share, North America dominated the global amniotic membrane market in 2017, partly due to penetration of newly approved products in the U.S. Western Europe, the second large market globally, with U.K., France and Germany being countries with high growth rates., is expected to gain 110 BPS in its market share over 2018–2028. APEJ is expected to be the third large market for amniotic membrane. APEJ and China collectively are expected to contribute over 15% share in the global market by 2028 over 2018.

The market for amniotic membrane is highly consolidated with top 5 players contributing over 60% of the revenue share in 2017. Examples of some of the key players identified in the global market are Integra LifeSciencesm Inc., MiMedx Group, Inc., Alliqua BioMedical, Inc., Skye Biologics Inc., Katena Products, Inc., Tissue-Tech Inc., Amnio Technology, LLC, Applied Biologics LLC, Human Regenerative Technologies, LLC, etc. Depth of research, along with proper documentation and statistical validation are factors that could determine a player’s success in the global amniotic membrane market

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-5044

Some of the key points identified in global amniotic membrane market are:

• FMI forecasts the global amniotic membrane market to grow at a CAGR of 9.3% over the forecast period by 2028 end. The growth in revenue generation across the amniotic membrane market is registered on the account of rise in amniotic membrane transplants in both developed and developing economies.
• The hospitals segment has proved to be the leading end user segment on account of increase in number of amniotic membrane transplants, growing awareness among the people about the benefits of the amniotic membrane transplant.
• Ease of FDA approval for novel and innovative amniotic membrane allografts coupled with adoption of amniotic membrane for varied applications would boost the revenue growth in Germany & the U.S. markets.
• Most often, apart from major applications including surgical wound and ophthalmology, the use of amniotic tissue in orthopaedic surgery, sports medicine and podiatry treatment has increased in the recent years.
• The amniotic membranes used majorly to treat human surgical wound needs to be FDA approved, thus amniotic membrane manufacturers focus on getting fast FDA approvals.

For in-depth insights, Download a PDF Brochure@ https://www.futuremarketinsights.com/reports/brochure/rep-gb-5044

Key Segments of Amniotic Membranes Market Industry Survey

Amniotic Membranes Market by Product Type:

• Cryopreserved Amniotic Membranes
• Lyophilized Amniotic Membranes

Amniotic Membranes Market by Application:

• Surgical Wounds
• Ophthalmology
• Others

Amniotic Membranes Market by End User:

• Amniotic Membrane Treatment in Hospitals
• Amniotic Membrane Treatment in Specialized Clinics
• Amniotic Membrane Treatment in Ambulatory Surgical Centres
• Amniotic Membrane Treatment in Academic Research Centres

Amniotic Membranes Market by Region:

• North America Amniotic Membranes Market
• Latin America Amniotic Membranes Market
• Europe Amniotic Membranes Market
• East Asia Amniotic Membranes Market
• South Asia & Pacific Amniotic Membranes Market
• Middle East & Africa (MEA) Amniotic Membranes Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs